Highlander Venture Fund has made its second investment, selecting Sensorygen as its latest portfolio company.
Sensorygen, a US-based mosquito repellent developer spun out from University of California (UC), Riverside, has received $50,000 in capital from Highlander Venture Fund (HVF).
HVF, a VC fund aimed at the institution’s ecosystem, has the option to provide Sensorygen with another $450,000, according to the fund’s managing director, Dave Schwab.
The deal marks the second investment for Highlander, following a $250,000 investment in US-based life science tools developer NanoCellect in January 2018. Schwab expects the fund to make additional commitments…
